List of Plexxikon Inc. patents

Patents where

Current Assignee

Name

Plexxikon Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8158636 Compounds and methods for kinase modulation, and indications therefor	Patent 8158636 was granted and assigned to Plexxikon Inc. on April, 2012 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8158636	April 17, 2012
‌ US Patent 8673928 Compounds and methods for kinase modulation, and indications therefor	Patent 8673928 was granted and assigned to Plexxikon Inc. on March, 2014 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8673928	March 18, 2014
‌ US Patent 9440969 Compounds and methods for kinase modulation, and indications therefor	Patent 9440969 was granted and assigned to Plexxikon Inc. on September, 2016 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	9440969	September 13, 2016
‌ US Patent 9096593 Compounds and methods for kinase modulation, and indications therefor	Patent 9096593 was granted and assigned to Plexxikon Inc. on August, 2015 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	9096593	August 4, 2015
‌ US Patent 11337976 Compounds and methods for kinase modulation, and indications therefor	Patent 11337976 was granted and assigned to Plexxikon Inc. on May, 2022 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	11337976	May 24, 2022
‌ US Patent 8129404 Compounds and uses thereof	Patent 8129404 was granted and assigned to Plexxikon Inc. on March, 2012 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8129404	March 6, 2012
‌ US Patent 8153641 Compounds and methods for kinase modulation, and indications therefor	Patent 8153641 was granted and assigned to Plexxikon Inc. on April, 2012 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8153641	April 10, 2012
‌ US Patent 8415469 Compounds and methods for kinase modulation, and indications therefor	Patent 8415469 was granted and assigned to Plexxikon Inc. on April, 2013 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8415469	April 9, 2013
‌ US Patent 10370374 Heterocyclic compounds and uses thereof	Patent 10370374 was granted and assigned to Plexxikon Inc. on August, 2019 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	10370374	August 6, 2019
‌ US Patent 10123998 Kinase modulation, and indications therefor	Patent 10123998 was granted and assigned to Plexxikon Inc. on November, 2018 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	10123998	November 13, 2018
‌ US Patent 9814714 Kinase modulation, and indications therefor	Patent 9814714 was granted and assigned to Plexxikon Inc. on November, 2017 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	9814714	November 14, 2017
‌ US Patent 10421761 Compounds for kinase modulation, and indications therefor	Patent 10421761 was granted and assigned to Plexxikon Inc. on September, 2019 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	10421761	September 24, 2019
‌ US Patent 9358235 Kinase modulation, and indications therefor	Patent 9358235 was granted and assigned to Plexxikon Inc. on June, 2016 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	9358235	June 7, 2016
‌ US Patent 7893075 Compounds modulating c-fms and/or c-kit activity and uses therefor	Patent 7893075 was granted and assigned to Plexxikon Inc. on February, 2011 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	7893075	February 22, 2011
‌ US Patent 8067434 Compounds and methods for development of Ret modulators	Patent 8067434 was granted and assigned to Plexxikon Inc. on November, 2011 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8067434	November 29, 2011
‌ US Patent 8722702 Compounds modulating c-fms and/or c-kit activity and uses therefor	Patent 8722702 was granted and assigned to Plexxikon Inc. on May, 2014 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	8722702	May 13, 2014
‌ US Patent 8461169 Compounds modulating c-fms and/or c-kit activity	Patent 8461169 was granted and assigned to Plexxikon Inc. on June, 2013 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8461169	June 11, 2013
‌ US Patent 9771363 Heterocyclic compounds and uses thereof	Patent 9771363 was granted and assigned to Plexxikon Inc. on September, 2017 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	9771363	September 26, 2017
‌ US Patent 9624213 Compounds and methods for kinase modulation, and indications therefor	Patent 9624213 was granted and assigned to Plexxikon Inc. on April, 2017 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	9624213	April 18, 2017
‌ US Patent 9873700 Compounds for kinase modulation, and indications therefor	Patent 9873700 was granted and assigned to Plexxikon Inc. on January, 2018 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	9873700	January 23, 2018
‌ US Patent 8053463 PPAR active compounds	Patent 8053463 was granted and assigned to Plexxikon Inc. on November, 2011 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	8053463	November 8, 2011
‌ US Patent 7572806 PPAR active compounds	Patent 7572806 was granted and assigned to Plexxikon Inc. on August, 2009 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	7572806	August 11, 2009
‌ US Patent 7863288 Compounds and methods for kinase modulation, and indications therefor	Patent 7863288 was granted and assigned to Plexxikon Inc. on January, 2011 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	7863288	January 4, 2011
‌ US Patent 9469640 Compounds and methods for kinase modulation, and indications therefor	Patent 9469640 was granted and assigned to Plexxikon Inc. on October, 2016 by the United States Patent and Trademark Office.	Plexxikon Inc.	Plexxikon Inc.	United States Patent and Trademark Office	9469640	October 18, 2016
‌ US Patent 7498342 Compounds modulating c-kit activity	Patent 7498342 was granted and assigned to Plexxikon Inc. on March, 2009 by the United States Patent and Trademark Office.		Plexxikon Inc.	United States Patent and Trademark Office	7498342	March 3, 2009

Results per page:

92 results

0 selected

92 results

0 selected